ArticleEndocrine2022
Successful dose escalation of lenvatinib for thyroid cancer after disease progression.
Chie Masaki et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleEndocrine2022
Chie Masaki et al.PubMed ↗Publisher ↗
No numbers read from the abstract.